Novo Nordisk
NVO
NVO
463 hedge funds and large institutions have $5.53B invested in Novo Nordisk in 2017 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 170 increasing their positions, 157 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 482 → 463 (-19)
20% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 61
42% less call options, than puts
Call options by funds: $11.3M | Put options by funds: $19.3M
Holders
463
Holding in Top 10
8
Calls
$11.3M
Puts
$19.3M
Top Buyers
| 1 | +$191M | |
| 2 | +$84.4M | |
| 3 | +$65.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$28.6M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$20.5M |
Top Sellers
| 1 | -$77.9M | |
| 2 | -$64.1M | |
| 3 | -$25.9M | |
| 4 |
DAC
Dividend Assets Capital
Ridgeland,
South Carolina
|
-$23.3M |
| 5 |
JP Morgan Chase
New York
|
-$22.5M |